ArticleJournal of microbiology and biotechnology2021
Bioactive Levan-Type Exopolysaccharide Produced by
Article in Journal of microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Process optimization and characterization of levan from Sporosarcina globispora MTCC 4776.Scientific reports · 2026Article
- Recent Advances in Microbial Levan Production: Strategies for Yield Enhancement and Sustainability.International journal of food science · 2026Review
- Analysis of cultivation conditions and enzymatic efficiency enables high-yield levan production from Bacillus velezensis KKSB6.Bioresources and bioprocessing · 2025Article
- Hydrogel Design Based on Bacterial Exopolysaccharides: The Biomedical Promise of Levan.International journal of molecular sciences · 2025Review
- Root colonization dynamics of alginate encapsulated rhizobacteria: implications forAIMS microbiology · 2025Article
- Interaction and effects of temperature preference under a controlled environment on the diversity and abundance of the microbiome inBiotechnology reports (Amsterdam, Netherlands) · 2024Article
- Advances in Microbial Exopolysaccharides: Present and Future Applications.Biomolecules · 2024Review
- Coculture of bacterial levans and evaluation of its anti-cancer activity against hepatocellular carcinoma cell lines.Scientific reports · 2024Article
- Article
- Elaboration of Nanostructured Levan-Based Colloid System as a Biological Alternative with Antimicrobial Activity for Applications in the Management of Pathogenic Microorganisms.Nanomaterials (Basel, Switzerland) · 2023Article
- Valorization of Using Agro-Wastes for Levan through Submerged Fermentation and Statistical Optimization of the Process Variables Applying Response Surface Methodology (RSM) Design.Microorganisms · 2023Article
- Exopolysaccharides Producing Bacteria: A Review.Microorganisms · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Levan is an industrially important, functional biopolymer with considerable applications in the food and pharmaceutical fields owing to its safety and biocompatibility. Here, levan-type exopolysaccharide produced by Pantoea agglomerans ZMR7 was purified by cold ethanol precipitation and characterized using TLC, FTIR,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.